Oncotartis

Developing tissue-specific anti-cancer drugs for hematological malignancies, breast, prostate, ovarian, melanoma

placeBuffalo, New York, United States calendar_todayFounded 2010 groups3 employees language oncotartis.com

Registered entities

Innovation

2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 195 times.

YearFilings
20151
20161
20171
20182
20191
20201
20211
20221
20251

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon